Related Experiment Videos
Myocardial reperfusion by thrombolysis after acute total left main artery occlusion--a case report
Insights
Thrombolytic therapy with streptokinase successfully treated acute left main coronary artery occlusion, even in patients with cardiogenic shock. This approach offers a new therapeutic option for acute myocardial infarction patients.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Acute myocardial infarction (AMI) treatment focuses on restoring blood flow.
- Left main coronary artery (LMCA) occlusion is a critical condition often requiring urgent intervention.
Observation:
- A patient with acute LMCA occlusion presented with cardiogenic shock.
- Successful reperfusion was achieved using thrombolytic therapy.
Findings:
- Thrombolytic therapy with streptokinase enabled myocardial reperfusion in acute LMCA occlusion.
- The patient underwent successful myocardial revascularization 72 hours after initial reperfusion.
Implications:
- Thrombolytic agents represent a viable therapeutic approach for acute LMCA occlusion, even in complex cases.
- Early reperfusion strategies can improve outcomes for patients with acute myocardial infarction and cardiogenic shock.
Abstract:
Coronary recanalization with thrombolytic agents is a new therapeutic approach to the treatment of acute myocardial infarction that can be beneficial even to patients in cardiogenic shock. Although few cases have been reported in the literature, treatment of acute occlusion of the left main coronary artery (LMCA) has been made possible by myocardial reperfusion. This communication concerns a patient with acute LMCA occlusion who was successfully treated by thrombolytic therapy with streptokinase followed by revascularization of the myocardium seventy-two hours after reperfusion was achieved.